Primary relevance to vitamin D Vitamin D is a stated subject of this paper.
Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.
Why this paper is included
Supporting source evidence:
Power calculations based on these parameters are presented in Fig. 1.Participant characteristics for the analytic sample from UK Biobank.UK BiobankParticipants333 025Age at baseline57.1 ± 8.1Sex Female177 745 (53.4) Male155 280 (46.6)25(OH)D concentration (nmol/L)55.4 ± 19.3Fibromyalgia cases2424 (0.7)Clinical fatigue cases6764 (2.0)Chronic widespread pain cases4279 (1.3)Probable lifetime major depression cases13 125 (3.9)BMI (kg/m2)27·3 ± 4·8SBP (mmHg)137·5 ± 18·6Smoking Current34 085 (10·2) Other298 940 (89·8)Diabetes Known history15 822 (4·8) No known history317 203 (95·2)Values represent mean ± standard deviation for continuous traits or N (%) for categorical traits. 25(OH)D concentrations are season-shifted to correspond to a measurement taken in autumn.Power to detect a causal effect of given effect size, representing an odds ratio per 10 nmol/L increase in genetically-predicted levels of 25(OH)D.
Source: Study population. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Genetic instrumental-variable study.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Meta-analysis unclear · Blinding unclear / not reported · Human research reported
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
Vitamin D, chronic pain, and depression: linear and non-linear Mendelian randomization analyses
Source: Article title.
The UK Biobank cohort comprises around 500,000 participants aged 40 to 69 years at baseline, recruited between 2006 to 2010 at 22 assessment centres throughout the UK, and followed up for a variety of health conditions from their recruitment date until July 2019 or their date of death.
Source: Methods.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
Vitamin D, chronic pain, and depression: linear and non-linear Mendelian randomization analyses
Genetic instrumental-variable study · Translational Psychiatry · 2024
Original publication title
Vitamin D, chronic pain, and depression: linear and non-linear Mendelian randomization analyses
© The Author(s) 2024
Original publication · Publisher record · CC BY 4.0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
What does the authors’ abstract report?
Vitamin D deficiency has been linked to various chronic pain conditions. However, randomized trials of vitamin D supplementation have had mixed results. In contrast, systematic reviews of randomized trials indicate a protective effect of vitamin D supplementation on depression. We undertake a Mendelian randomization investigation in UK Biobank, a study of UK residents aged 40-65 at recruitment. We perform linear and non-linear Mendelian randomization analyses for four outcomes: fibromyalgia, clinical fatigue, chronic widespread pain, and probable lifetime major depression. We use genetic variants from four gene regions with known links to vitamin D biology as instruments.
In linear analyses, genetically-predicted levels of 25-hydroxyvitamin D [25(OH)D], a clinical marker of vitamin D status, were not associated with fibromyalgia (odds ratio [OR] per 10 nmol/L higher 25(OH)D 1.02, 95% confidence interval [CI] 0.93, 1.12), clinical fatigue (OR 0.99, 95% CI 0.94, 1.05), chronic widespread pain (OR 0.95, 95% CI 0.89, 1.02), or probable lifetime major depression (OR 0.97, 95% CI 0.93, 1.01). In non-linear analyses, an association was observed between genetically-predicted 25(OH)D levels and depression in the quintile of the population with the lowest 25(OH)D levels (OR 0.75, 95% CI 0.59, 0.94); associations were null in other strata.
Our findings suggest that population-wide vitamin D supplementation will not substantially reduce pain or depression; however, targeted supplementation of deficient individuals may reduce risk of depression.
Authors’ abstract
Vitamin D deficiency has been linked to various chronic pain conditions. However, randomized trials of vitamin D supplementation have had mixed results. In contrast, systematic reviews of randomized trials indicate a protective effect of vitamin D supplementation on depression. We undertake a Mendelian randomization investigation in UK Biobank, a study of UK residents aged 40-65 at recruitment. We perform linear and non-linear Mendelian randomization analyses for four outcomes: fibromyalgia, clinical fatigue, chronic widespread pain, and probable lifetime major depression. We use genetic variants from four gene regions with known links to vitamin D biology as instruments.
In linear analyses, genetically-predicted levels of 25-hydroxyvitamin D [25(OH)D], a clinical marker of vitamin D status, were not associated with fibromyalgia (odds ratio [OR] per 10 nmol/L higher 25(OH)D 1.02, 95% confidence interval [CI] 0.93, 1.12), clinical fatigue (OR 0.99, 95% CI 0.94, 1.05), chronic widespread pain (OR 0.95, 95% CI 0.89, 1.02), or probable lifetime major depression (OR 0.97, 95% CI 0.93, 1.01). In non-linear analyses, an association was observed between genetically-predicted 25(OH)D levels and depression in the quintile of the population with the lowest 25(OH)D levels (OR 0.75, 95% CI 0.59, 0.94); associations were null in other strata.
Our findings suggest that population-wide vitamin D supplementation will not substantially reduce pain or depression; however, targeted supplementation of deficient individuals may reduce risk of depression.
Publication and source details
Original title: Vitamin D, chronic pain, and depression: linear and non-linear Mendelian randomization analyses
Emily Bassett; Eva Gjekmarkaj; Amy M. Mason; Sizheng Steven Zhao; Stephen Burgess
Translational Psychiatry · 2024
© The Author(s) 2024https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.https://doi.org/10.13039/100004440Wellcome Trust (Wellcome)225790/Z/22/ZBurgess Stephen https://doi.org/10.13039/501100000265RCUK | Medical Research Council (MRC)MC_UU_00002/7Burgess Stephen https://doi.org/10.13039/501100000272DH | National Institute for Health Research (NIHR)NIHR203312Clinical LectureshipZhao Sizheng Steven Burgess StephenRepository JATS snapshot; version as supplied
Source retrieved: 2026-11-11T04:11:53.372978+00:00
DOI: 10.1038/s41398-024-02997-7 · PMC11224391